Cargando…

Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles †

Phosphodiesterase 7 (PDE7) is an enzyme responsible for the degradation of cyclic adenosine monophosphate (cAMP), an important cellular messenger. PDE7’s role in neurotransmission, expression profile in the brain and the druggability of other phosphodiesterases have motivated the search for potent i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nozal, Vanesa, Rojas-Prats, Elisa, Maestro, Inés, Gil, Carmen, Perez, Daniel I., Martinez, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004175/ https://www.ncbi.nlm.nih.gov/pubmed/33809846 http://dx.doi.org/10.3390/ijms22063206

Ejemplares similares

Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles
por: Rojas-Prats, Elisa, et al.
Publicado: (2021)

A comparison of acyl-moieties for noncovalent functionalization of PLGA and PEG-PLGA nanoparticles with a cell-penetrating peptide
por: Paulino da Silva Filho, Omar, et al.
Publicado: (2021)

Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles
por: Fodor-Kardos, Andrea, et al.
Publicado: (2020)

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
por: Ginex, Tiziana, et al.
Publicado: (2021)

Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery
por: Lu, Boting, et al.
Publicado: (2019)

A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles
por: Sousa, Flávia, et al.
Publicado: (2017)

PLGA/xylitol nanoparticles enhance antibiofilm activity via penetration into biofilm extracellular polymeric substances
por: Anjum, Anam, et al.
Publicado: (2019)

Externally Controlled Triggered-Release of Drug from PLGA Micro and Nanoparticles
por: Hua, Xin, et al.
Publicado: (2014)

Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres
por: Lee, Jimin, et al.
Publicado: (2022)

Microfluidics as tool to prepare size-tunable PLGA nanoparticles with high curcumin encapsulation for efficient mucus penetration
por: Lababidi, Nashrawan, et al.
Publicado: (2019)

Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma
por: Ma, Chenjun, et al.
Publicado: (2021)

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
por: Choi, Yongwhan, et al.
Publicado: (2020)

Evaluation of Cell Proliferation and Wound Healing Effects of Vitamin A Palmitate-Loaded PLGA/Chitosan-Coated PLGA Nanoparticles: Preparation, Characterization, Release, and Release Kinetics
por: Baghirova, Lala, et al.
Publicado: (2023)

PLGA Biodegradable Nanoparticles Containing Perphenazine or Chlorpromazine Hydrochloride: Effect of Formulation and Release
por: Halayqa, Mohammed, et al.
Publicado: (2014)

Enhanced sustained release of furosemide in long circulating chitosan-conjugated PLGA nanoparticles
por: Kashyap, Sapna, et al.
Publicado: (2019)

PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo
por: Su, Yue, et al.
Publicado: (2022)

PLGA–TiO(2) as a Carrier System for Drug Release
por: Torres-Ramos, M. I., et al.
Publicado: (2022)

Optically Coupled PtOEP and DPA Molecules Encapsulated into PLGA-Nanoparticles for Cancer Bioimaging
por: Vepris, Olena, et al.
Publicado: (2022)

A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles
por: Pourtalebi Jahromi, Leila, et al.
Publicado: (2020)

Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits
por: Rezaeian Shiadeh, Seyedeh Nesa, et al.
Publicado: (2023)

Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles
por: Pakulska, Malgosia M., et al.
Publicado: (2016)

Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
por: Reardon, Philip JT, et al.
Publicado: (2017)

Development of composite PLGA microspheres containing exenatide-encapsulated lecithin nanoparticles for sustained drug release
por: Dong, Ni, et al.
Publicado: (2020)

Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug
por: Ryu, Suji, et al.
Publicado: (2021)

Design, Development, Physicochemical Characterization, and In Vitro Drug Release of Formoterol PEGylated PLGA Polymeric Nanoparticles
por: Vallorz, Ernest L., et al.
Publicado: (2022)

Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin
por: Cardoso, M. Margarida, et al.
Publicado: (2021)

PLGA-Based Nanoparticles in Cancer Treatment
por: Rezvantalab, Sima, et al.
Publicado: (2018)

PEG–PLGA nanoparticles for encapsulating ciprofloxacin
por: Watcharadulyarat, Natsorn, et al.
Publicado: (2023)

Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles
por: Chung, Eugene P., et al.
Publicado: (2020)

Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
por: Rafiei, Pedram, et al.
Publicado: (2017)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
por: Babos, György, et al.
Publicado: (2018)

Reduced Cardiotoxicity of Ponatinib-Loaded PLGA-PEG-PLGA Nanoparticles in Zebrafish Xenograft Model
por: Al-Thani, Hissa F., et al.
Publicado: (2022)

Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles
por: Grassi, G, et al.
Publicado: (2006)

Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats
por: Anwer, Md Khalid, et al.
Publicado: (2019)

Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy
por: Lee, Pei-Chi, et al.
Publicado: (2019)

Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
por: Kim, Jeongrae, et al.
Publicado: (2022)

The PLGA nanoparticles for sustainable release of CGRP to ameliorate the inflammatory and vascular disorders in the lung of CGRP-deficient rats
por: Wang, Fang, et al.
Publicado: (2021)

Simulation of Drug Release from PLGA Particles In Vivo
por: Sasaki, Kaori, et al.
Publicado: (2013)

Heuristic modeling of macromolecule release from PLGA microspheres
por: Szlęk, Jakub, et al.
Publicado: (2013)

Insulin-loaded PLGA microspheres for glucose-responsive release
por: Wu, Jun-Zi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f0u2g9blfrrfjsniv51og48trn